{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:45:35Z","timestamp":1789469135834,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National\u2002Natural\u2002Science\u2002Foundation\u2002of\u2002China","doi-asserted-by":"crossref","award":["82370199"],"award-info":[{"award-number":["82370199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2023-I2M-1-001"],"award-info":[{"award-number":["2023-I2M-1-001"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-CICAMS-80102022203"],"award-info":[{"award-number":["2022-CICAMS-80102022203"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07144-4","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:34:28Z","timestamp":1782279268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of age and primary treatment with risk of non-lymphoma-related death and long-term survival outcomes in adult patients with early-stage follicular lymphoma: a population-based analysis"],"prefix":"10.1007","volume":"105","author":[{"given":"Chang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Zi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Ye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Wen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-Ning","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Nan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0985-235X","authenticated-orcid":false,"given":"Ye-Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"7144_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720\u20131748","journal-title":"Leukemia"},{"key":"7144_CR2","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1200\/JCO.2008.18.1495","volume":"27","author":"JW Friedberg","year":"2009","unstructured":"Friedberg JW, Taylor MD, Cerhan JR et al (2009) Follicular lymphoma in the United States: first report of the national LymphoCare study. J Clin Oncol 27:1202\u20131208","journal-title":"J Clin Oncol"},{"key":"7144_CR3","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41375-020-01048-6","volume":"35","author":"MAW Dinnessen","year":"2021","unstructured":"Dinnessen MAW, van der Poel MWM, Tonino SH et al (2021) Stage-specific trends in primary therapy and survival in follicular lymphoma: a nationwide population-based analysis in the Netherlands, 1989\u20132016. Leukemia 35:1683\u20131695","journal-title":"Leukemia"},{"key":"7144_CR4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/ajh.25696","volume":"95","author":"A Freedman","year":"2020","unstructured":"Freedman A, Jacobsen E (2020) Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol 95:316\u2013327","journal-title":"Am J Hematol"},{"key":"7144_CR5","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3109\/0284186X.2014.974829","volume":"54","author":"BK Shah","year":"2015","unstructured":"Shah BK, Ghimire KB (2015) Survival in adult stage I follicular lymphoma treated with and without radiotherapy - a population-based study. Acta Oncol 54:951\u2013953","journal-title":"Acta Oncol"},{"key":"7144_CR6","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1002\/cncr.29491","volume":"121","author":"JA Vargo","year":"2015","unstructured":"Vargo JA, Gill BS, Balasubramani GK et al (2015) What is the optimal management of early-stage low-grade follicular lymphoma in the modern era? Cancer 121:3325\u20133334","journal-title":"Cancer"},{"key":"7144_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/10428194.2023.2283296","volume":"65","author":"Q Zhong","year":"2024","unstructured":"Zhong Q, Liu Y, Wu Y et al (2024) Impact of age on long-term relative survival benefit of radiotherapy for early-stage grade I-II follicular lymphoma from the SEER database (2000\u20132015). Leuk Lymphoma 65:312\u2013322","journal-title":"Leuk Lymphoma"},{"key":"7144_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.annonc.2020.11.008","volume":"32","author":"M Dreyling","year":"2021","unstructured":"Dreyling M, Ghielmini M, Rule S et al (2021) Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 32:298\u2013308","journal-title":"Ann Oncol"},{"key":"7144_CR9","unstructured":"NCCN (2025) NCCN Clinical Practice Guidelines in Oncology: B-cell Lymphoma (Version 2.2025)"},{"key":"7144_CR10","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1182\/bloodadvances.2019000458","volume":"3","author":"JWD Tobin","year":"2019","unstructured":"Tobin JWD, Rule G, Colvin K et al (2019) Outcomes of stage I\/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance. Blood Adv 3:2804\u20132811","journal-title":"Blood Adv"},{"key":"7144_CR11","doi-asserted-by":"publisher","first-page":"e1236","DOI":"10.1634\/theoncologist.2019-0138","volume":"24","author":"MJ Matasar","year":"2019","unstructured":"Matasar MJ, Luminari S, Barr PM et al (2019) Follicular lymphoma: recent and emerging therapies, treatment strategies, and remaining unmet needs. Oncologist 24:e1236\u2013e1250","journal-title":"Oncologist"},{"key":"7144_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","volume":"89","author":"T Illidge","year":"2014","unstructured":"Illidge T, Specht L, Yahalom J et al (2014) Modern radiation therapy for nodal non-hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 89:49\u201358","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7144_CR13","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1200\/JCO.2018.77.9892","volume":"36","author":"M MacManus","year":"2018","unstructured":"MacManus M, Fisher R, Roos D et al (2018) Randomized trial of systemic therapy after involved-field radiotherapy in patients with early-stage follicular lymphoma: TROG 99.03. J Clin Oncol 36:2918\u20132925","journal-title":"J Clin Oncol"},{"issue":"4","key":"7144_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","volume":"12","author":"A Berrington de Gonzalez","year":"2011","unstructured":"Berrington de Gonzalez A, Curtis RE, Kry SF et al (2011) Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 12(4):353\u201360","journal-title":"Lancet Oncol"},{"key":"7144_CR15","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1200\/JCO.22.02320","volume":"41","author":"JE Bates","year":"2023","unstructured":"Bates JE, Shrestha S, Liu Q et al (2023) Cardiac substructure radiation dose and risk of late cardiac disease in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 41:3826\u20133838","journal-title":"J Clin Oncol"},{"issue":"9","key":"7144_CR16","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1038\/s41591-023-02514-1","volume":"29","author":"Y Wang","year":"2023","unstructured":"Wang Y, Ronckers CM, van Leeuwen FE et al (2023) Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer. Nat Med 29(9):2268\u20132277","journal-title":"Nat Med"},{"issue":"34","key":"7144_CR17","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1200\/JCO.19.00129","volume":"37","author":"LM Turcotte","year":"2019","unstructured":"Turcotte LM, Liu Q, Yasui Y et al (2019) Chemotherapy and risk of subsequent malignant neoplasms in the Childhood Cancer Survivor Study Cohort. J Clin Oncol 37(34):3310\u20133319","journal-title":"J Clin Oncol"},{"key":"7144_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S1470-2045(24)00157-8","volume":"25","author":"RA Hammoud","year":"2024","unstructured":"Hammoud RA, Liu Q, Dixon SB et al (2024) The burden of cardiovascular disease and risk for subsequent major adverse cardiovascular events in survivors of childhood cancer: a prospective, longitudinal analysis from the St Jude Lifetime Cohort Study. Lancet Oncol 25:811\u2013822","journal-title":"Lancet Oncol"},{"key":"7144_CR19","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ijrobp.2013.11.225","volume":"88","author":"AJ Olszewski","year":"2014","unstructured":"Olszewski AJ, Desai A (2014) Radiation therapy administration and survival in stage I\/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Int J Radiat Oncol Biol Phys 88:642\u2013649","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"7144_CR20","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin PC, Fine JP (2017) Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med 36:4391\u20134400","journal-title":"Stat Med"},{"key":"7144_CR21","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB (2007) Tutorial in biostatistics: competing risks and multi-state models. Stat Med 26:2389\u20132430","journal-title":"Stat Med"},{"key":"7144_CR22","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/jnci\/80.15.1198","volume":"80","author":"FE Harrell","year":"1988","unstructured":"Harrell FE, Lee KL, Pollock BG (1988) Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 80:1198\u20131202","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"7144_CR23","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/sim.5753","volume":"32","author":"DF McCaffrey","year":"2013","unstructured":"McCaffrey DF, Griffin BA, Almirall D et al (2013) A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med 32(19):3388\u20133414","journal-title":"Stat Med"},{"key":"7144_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2282652","volume":"55","author":"Y Liu","year":"2023","unstructured":"Liu Y, Chu Y, Liu J et al (2023) Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis. Ann Med 55:2282652","journal-title":"Ann Med"},{"key":"7144_CR25","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/bjh.16090","volume":"187","author":"REI Prusila","year":"2019","unstructured":"Prusila REI, Sorigue M, Jauhiainen J et al (2019) Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era. Br J Haematol 187:364\u2013371","journal-title":"Br J Haematol"},{"key":"7144_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/14737140.2018.1409626","volume":"18","author":"MG Kamel","year":"2018","unstructured":"Kamel MG, El-Qushayri AE, Thach TQ et al (2018) Cardiovascular mortality trends in non-Hodgkin\u2019s lymphoma: a population-based cohort study. Expert Rev Anticancer Ther 18:91\u2013100","journal-title":"Expert Rev Anticancer Ther"},{"key":"7144_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","volume":"100","author":"L Lowry","year":"2011","unstructured":"Lowry L, Smith P, Qian W et al (2011) Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol 100:86\u201392","journal-title":"Radiother Oncol"},{"key":"7144_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S1470-2045(20)30686-0","volume":"22","author":"P Hoskin","year":"2021","unstructured":"Hoskin P, Popova B, Schofield O et al (2021) 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. Lancet Oncol 22:332\u2013340","journal-title":"Lancet Oncol"},{"key":"7144_CR29","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1016\/S2352-3026(25)00071-7","volume":"12","author":"XY Wang","year":"2025","unstructured":"Wang XY, Zhang XM, Wang L et al (2025) Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Haematol 12:e442\u2013e450","journal-title":"Lancet Haematol"},{"key":"7144_CR30","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.ijrobp.2020.03.019","volume":"107","author":"A Wirth","year":"2020","unstructured":"Wirth A, Mikhaeel NG, Aleman BMP et al (2020) Involved site radiation therapy in adult lymphomas: An overview of International Lymphoma Radiation Oncology Group Guidelines. Int J Radiat Oncol Biol Phys 107:909\u2013933","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"7144_CR31","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1182\/blood.2019004588","volume":"136","author":"AC Lo","year":"2020","unstructured":"Lo AC, Campbell BA, Pickles T et al (2020) Long-term outcomes for patients with limited-stage follicular lymphoma: update of a population-based study. Blood 136(8):1006\u20131010","journal-title":"Blood"},{"key":"7144_CR32","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1038\/leu.2010.218","volume":"24","author":"DA Carney","year":"2010","unstructured":"Carney DA, Westerman DA, Tam CS et al (2010) Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy. Leukemia 24:2056\u20132062","journal-title":"Leukemia"},{"key":"7144_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.amjcard.2023.09.035","volume":"210","author":"MC Tan","year":"2024","unstructured":"Tan MC, Yeo YH, Ibrahim R et al (2024) Trends and disparities in cardiovascular death in non-Hodgkin lymphoma. Am J Cardiol 210:276\u2013278","journal-title":"Am J Cardiol"},{"key":"7144_CR34","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1182\/bloodadvances.2021004939","volume":"5","author":"BS Imber","year":"2021","unstructured":"Imber BS, Chau KW, Lee J et al (2021) Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients? Blood Adv 5:4185\u20134197","journal-title":"Blood Adv"},{"issue":"1","key":"7144_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11899-021-00614-8","volume":"16","author":"J Girard","year":"2021","unstructured":"Girard J, Karimi Y, Carty S et al (2021) Targeted therapies for follicular lymphoma. Curr Hematol Malig Rep 16(1):25\u201331","journal-title":"Curr Hematol Malig Rep"},{"issue":"11","key":"7144_CR36","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1182\/blood.2020008243","volume":"139","author":"J Trotman","year":"2022","unstructured":"Trotman J, Pettitt AR (2022) Is it time for PET-guided therapy in follicular lymphoma? Blood 139(11):1631\u20131641","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07144-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07144-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07144-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:43:09Z","timestamp":1789465389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07144-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["7144"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07144-4","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is based on data from the Surveillance, Epidemiology, and End Results (SEER) public database. Since the SEER database contains de-identified patient information, no ethical approval or informed consent was required for this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used de-identified data from the Surveillance, Epidemiology, and End Results (SEER) public database. As the SEER database contains anonymized patient information, consent for publication was not required.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical trail number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"372"}}